• Chỉ mục bởi
  • Năm xuất bản
LIÊN KẾT WEBSITE

Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations

Pham P.V. Stem Cell Institute, University of Science, Ho Chi Minh, 08000, Viet Nam|
Vu N.B. Vietnam National University, Ho Chi Minh, 08000, Viet Nam|

World Journal of Stem Cells Số 8, năm 2020 (Tập 12, trang 721-730)

ISSN: 19480210

ISSN: 19480210

DOI: 10.4252/WJSC.V12.I8.721

Tài liệu thuộc danh mục: Scopus

Article

English

Từ khóa: Article; coronavirus disease 2019; human; human cell; mesenchymal stem cell; mesenchymal stem cell transplantation; umbilical cord; wound healing
Tóm tắt tiếng anh
Coronavirus disease-2019 (COVID-19) has affected more than 200 countries worldwide. This disease has hugely affected healthcare systems as well as the economy to an extent never seen before. To date, COVID-19 infection has led to about 165000 deaths in 150 countries. At present, there is no specific drug or efficient treatment for this disease. In this analysis based on evidential relationships of the biological characteristics of MSCs, especially umbilical cord (UC)-derived MSCs as well as the first clinical trial using MSCs for COVID-19 treatment, we discuss the use of UC-MSCs to improve the symptoms of COVID-19 in patients. �The Author(s) 2020.

Xem chi tiết